Roche Molecular Systems, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$12Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
422clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| David Schlossman | Columbia, MO | Hematology & Oncology | $1,247,945.64 |
| Guadalupe Manriquez | Tucson, AZ | Anatomic Pathology & Clinical Pathology | $936,332.78 |
| Soham Shah | Bakersfield, CA | Hospitalist | $843,755.16 |
| Michael Lynch | Tucson, AZ | Anatomic Pathology & Clinical Pathology | $833,099.05 |
| Lawrence Loeb | Bellevue, WA | Internal Medicine | $784,150.55 |
| Ghassan Tranesh | Tucson, AZ | Anatomic Pathology & Clinical Pathology | $760,908.37 |
| Gordana Juric-Sekhar | Seattle, WA | Neuropathology | $688,117.69 |
| Gruschenka Mojica Sanchez | Baltimore, MD | $625,941.04 | |
| Bingbing Song | Loma Linda, CA | $559,362.10 | |
| Brian Cone | Los Angeles, CA | Anatomic Pathology & Clinical Pathology | $517,025.07 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.